Medical condition |
(Viruses, Human Immunodeficiency) OR (AIDS Virus) OR (AIDS Viruses) OR (Virus, AIDS) OR (Viruses, AIDS) OR (HTLV-III) OR (Human Immunodeficiency Virus) OR (Human Immunodeficiency Viruses) OR (Human T Cell Lymphotropic Virus Type III) OR (Human T Lymphotropic Virus Type III) OR (Human T-Cell Leukemia Virus Type III) OR (Human T-Cell Leukemia Virus Type III) OR (Human T-Cell Lymphotropic Virus Type III) OR (Human T-Cell Lymphotropic Virus Type III) OR (Immunodeficiency Virus, Human) OR (Immunodeficiency Viruses, Human) OR (LAV-HTLV-III) OR (Lymphadenopathy-Associated Virus) OR (Lymphadenopathy-Associated Virus) OR (Lymphadenopathy-Associated Viruses) OR (Virus, Lymphadenopathy-Associated) OR (Viruses, Lymphadenopathy-Associated) OR (Virus, Human Immunodeficiency) OR (Acquired Immune Deficiency Syndrome Virus) OR (Acquired Immunodeficiency Syndrome Virus) OR (aids associated lentivirus) OR (aids associated retrovirus) OR (aids associated virus) OR (aids related virus) OR HIV OR (immunodeficiency associated virus) OR (immunodeficiency viruses primate) OR lav OR (LAV (AIDS)) OR (lentiviruses, primate) OR (lymphadenopathy associated retrovirus) OR (Lymphadenopathy associated virus) OR (virus, lymphadenopathy associated) |
Intervention |
Efavirenz OR EFV OR EFZ OR (efavirenz, (R)-isomer) OR Sustiva OR (L 743726) OR (L-743,726) OR (L-743726) OR (L 743,726) OR Stocrin OR (Merck Sharp and Dohme brand of efavirenz) OR (DMP 266) OR (DMP-266) OR (dmp266) OR efavir OR filginase OR l743726 OR (efavirenz, (S)-isomer) OR (virorrever) |
Methodological limits |
PubMed: Humans, Randomized Controlled Trial; EMBASE: Humans, Randomized Controlled Trial, Embase only; CENTRAL: No limits applied; word variations have been searched |